Decernotinib
Overview of the drug Decernotinib
Decernotinib | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Decernotinib is a Janus kinase inhibitor (JAK inhibitor) that has been investigated for its potential use in the treatment of rheumatoid arthritis. It specifically targets the JAK3 enzyme, which plays a crucial role in the signaling pathways of various cytokines involved in the immune response.
Mechanism of Action[edit | edit source]
Decernotinib functions by selectively inhibiting the activity of the JAK3 enzyme. JAK3 is associated with the common gamma chain of cytokine receptors, which are critical for the signaling of several interleukins, including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. By inhibiting JAK3, decernotinib disrupts these signaling pathways, leading to a reduction in the inflammatory response that characterizes autoimmune diseases such as rheumatoid arthritis.
Clinical Development[edit | edit source]
Decernotinib has undergone various phases of clinical trials to assess its efficacy and safety in patients with rheumatoid arthritis. These trials have focused on its ability to reduce the symptoms of the disease, such as joint pain and swelling, and to improve overall physical function.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of decernotinib includes its absorption, distribution, metabolism, and excretion. It is administered orally and has been shown to have a predictable absorption pattern. The drug is metabolized primarily in the liver and excreted through both renal and fecal pathways.
Side Effects[edit | edit source]
Common side effects observed in clinical trials of decernotinib include headache, nausea, and upper respiratory tract infection. As with other JAK inhibitors, there is a potential risk of serious infections due to the suppression of the immune system.
Potential Applications[edit | edit source]
While primarily investigated for rheumatoid arthritis, the mechanism of action of decernotinib suggests potential applications in other autoimmune diseases where JAK3 plays a role. These could include conditions such as psoriasis and inflammatory bowel disease.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD